Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 12Unknown 3Terminated 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, T-Cell, Peripheral 1Lymphoma, Follicular 1Lymphoma, B-Cell 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × Transplantation, Autologous × Clear all
NCT04489264 2020-12-04

The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma

Peking University

Unknown
60 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03681938 2018-09-24

Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?

Institut Paoli-Calmettes

Unknown
183 enrolled
Lymphoid

Lymphoma, B-Cell

NCT00435955 2007-02-16

Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma

Azienda Ospedaliera San Giovanni Battista

Phase 3 Unknown
240 enrolled
Lymphoid

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡